Skip to main content

MoneyWorks4Me

Transgene Biotek informs about board meeting

03 Nov 2021 Evaluate

Transgene Biotek has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021, to consider and approve the unaudited standalone & consolidated financial results for the quarter and half year ended on 30th September 2021; and to examine and take note of the Limited Review Report as provided by the Statutory Auditor of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 43.70
Prime Focus 274.60
Indegene 665.85
Syngene Internatl. 447.65
Knowledge RealtyTrt. 111.28
View more..